Therapies for Addressing Mental Health Care in the Workplace

Therapies for Addressing Mental Health Care in the Workplace

Mental health issues like depression and anxiety are leading drivers of workplace absenteeism and reduced productivity, costing employers up to $225 billion annually. While traditional treatments such as SSRIs and therapy are commonly used, up to 60% of people with mental health conditions are treatment-resistant, leaving many employees without effective care.   

Ketamine-assisted therapy (KAT) offers a fast-acting and effective alternative for mental health conditions, including depression, anxiety, and PTSD. Backed by clinical research, KAT is one of the few legal psychedelic treatments with FDA approval. This webinar will explore the legal and regulatory landscape, the science behind ketamine's therapeutic effects, and how employers can integrate this into their health plans. Real-world examples and case studies will demonstrate the significant benefits for both employees and employers.  

Key Takeaways:

• Review the legal and regulatory status of ketamine and other psychedelic therapies.
  
  
• Understand the latest research on how ketamine treats depression, anxiety, and PTSD.  
  
  
• Explore the benefits to employers in offering ketamine-assisted therapy, including cost savings and improved employee outcomes.  
  
  
• Learn how to integrate ketamine therapy into existing benefits packages.  

Join us for an informative session on how ketamine and psychedelic therapies can be part of a forward-thinking approach to mental health care in the workplace. 

For Health Action Council members only
SHRM, HRCI, and CEBS credit